Table 1.
Demographics and Baseline Characteristics of the Evaluable Population
| T1D (n = 38) | T2D (n = 26) | P | All, N = 64 | |
|---|---|---|---|---|
| Age, years | 42.3 ± 11.6 | 55.7 ± 6.8 | <0.001 | 47.7 ± 11.9 |
| Men | 25 (62) | 13 (52) | 0.18 | 38 (56) |
| Hispanic or Latino | 5 (13.2) | 6 (23.1) | 0.49 | 11 (17.2) |
| Race | 0.046 | |||
| White | 38 (100) | 20 (76.9) | 62 (90.6) | |
| Black or African American | 0 (0.0) | 3 (11.5) | 3 (4.7) | |
| American Indian or Alaska Native | 0 (0.0) | 1 (3.8) | 1 (1.6) | |
| Asian | 0 (0.0) | 1 (3.8) | 1 (1.6) | |
| Multiple | 0 (0.0) | 1 (3.8) | 1 (1.6) | |
| BMI, kg/m2 | 27.6 ± 5.5 | 34.4 ± 4.8 | <0.001 | 30.4 ± 6.2 |
| HbA1c, % | 9.4 ± 2.0 | 9.7 ± 1.4 | 0.52 | 9.6 ± 1.8 |
| Diabetes duration, years | 22.1 ± 11.6 | 16.5 ± 7.3 | 0.009 | 19.8 (10.4) |
| Preenrollment bolus insulin | ||||
| Lispro U-100 | 22 (57.9) | 13 (50.0) | 35 (54.7) | |
| Aspart | 15 (39.5) | 13 (50.0) | 28 (43.8) | |
| Glulisine | 1 (2.6) | 0 (0.0) | 1 (1.6) | |
Evaluable population, N = 64. Data are mean ± SD or n (%).
BMI, body mass index; HbA1c, glycated hemoglobin; SD, standard deviation; T1D, type 1 diabetes; T2D, type 2 diabetes.